Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase NA 1Phase 2 1

Status

Completed 46Unknown 15Terminated 4Not yet recruiting 4Withdrawn 3Recruiting 2Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Pain 2Pain, Postoperative 1Neoplasms 1Kidney Neoplasms 1Feeding and Eating Disorders 1Colorectal Neoplasms 1Breast Neoplasms 1

Interventions

Cyclophosphamide 390Carboplatin 344Gemcitabine 332pembrolizumab 329Cisplatin 328Paclitaxel 297Radiotherapy 296Docetaxel 286Bevacizumab 253Rituximab 234Capecitabine 223Nivolumab 220Dexamethasone 206Fluorouracil 190fludarabine 177Oxaliplatin 177Pemetrexed 153Doxorubicin 153Irinotecan 148Leucovorin 144Etoposide 144Cytarabine 133Cetuximab 129Bortezomib 129fludarabine phosphate 128Lenalidomide 126Erlotinib Hydrochloride 120Filgrastim 119Temozolomide 113Radiosurgery 113

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Terminated × Ropivacaine × Clear all
NCT02525211 2026-04-21

Continues Cicatricial Perfusion of Ropivacaine Versus Placebo After Mastectomy : Rehabilitation After Treatment

Institut Paoli-Calmettes

Phase 3 Terminated
59 enrolled
Breast

Breast Neoplasms

NCT04085237 2024-02-16

ESP Block for Laparoscopic Nephrectomy Surgeries

McMaster University

Phase NA Terminated
10 enrolled
Genitourinary

Kidney Neoplasms, Pain, Postoperative

NCT04250805 2024-01-31

GASTROXY

Centre Hospitalier Universitaire de Saint Etienne

Phase 2 Terminated
17 enrolled

Feeding and Eating Disorders, Neoplasms, Pain

NCT01318161 2021-02-16

EPICOL

Örebro University, Sweden

Phase 3 Terminated
221 enrolled
Gastrointestinal

Pain, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡